AXDCARE brand logo

Industry News · Compliance & Documentation

Medical Device Label Symbols: An Importer Review Before Artwork Approval

Review medical device label symbols by market, source standard, glossary needs, product scope, artwork revision, and production handoff before approval.

2026-10-104 min readAXDCARE Editorial TeamShare
Importer compliance team reviewing medical device label symbols and packaging artwork
A label-symbol review should connect artwork, source references, market requirements, and glossary planning before approval.

Preface

Medical device label symbols can compress important information into limited packaging space, but a familiar-looking icon is not automatically appropriate for every device or destination market. Importers need to know where a symbol came from, what it means in the applicable labeling system, whether explanatory text or a glossary is required, and which released product configuration it describes.

This article is a review framework, not a universal symbol list. Market requirements, recognized standards, device-specific controls, and the responsible legal manufacturer or importer should be checked for the actual project before artwork approval.

01

Build a market-specific symbol inventory

Start with every symbol proposed for the unit label, carton, instructions, accessories, and any electronic labeling. Record its source, intended meaning, destination market, device or component scope, and the document owner who approved it. Avoid copying symbols from a competitor carton or an unrelated product family.

The inventory should distinguish regulatory or safety information from logistics graphics, recycling information, handling marks, internal production codes, and marketing icons. Similar visual styles do not make these categories interchangeable.

Artwork specialist comparing symbol source sheet with medical device carton panels
Artwork specialists should trace each proposed symbol to a controlled source and the exact carton panel where it will appear.

02

Verify the source standard and current recognition status

For U.S. projects, FDA maintains guidance on the use of symbols in labeling and a database of recognized consensus standards. FDA currently lists ISO 15223-1:2021 with Amendment 1:2025 in its recognition database, but project teams still need to confirm the applicable requirements, transition considerations, and symbol meaning for the product under review.

Do not treat a standards title as automatic permission to place every symbol on every carton. The team must map each chosen symbol to the actual device, storage condition, manufacturer information, date control, sterility status, warning, or other verified attribute it is intended to communicate.

Reviewers inspecting a medical device label proof beside a market matrix and glossary sheet
Final-size inspection links legibility, explanatory content, and destination-market decisions to the physical proof.

03

Decide whether adjacent text or a glossary is required

FDA guidance describes conditions under which certain symbols may appear without adjacent explanatory text. When a standalone symbol requires a glossary, the labeling should identify the glossary location as required and the explanation must be available in the controlled labeling set.

For multi-market artwork, do not assume one glossary strategy satisfies every jurisdiction or language plan. Review adjacent text, electronic references, manual placement, translations, and package-space constraints together rather than after the carton layout is locked.

Factory prepress team confirming medical device packaging artwork version handoff
The production handoff should identify the released proof and prevent archived artwork from returning to print.

Middle Article Support

Align symbols with the complete labeling set

Use the IFU review workflow to connect carton symbols, explanatory text, glossary content, languages, and the released manual revision.

Review IFU Workflow

04

Map every symbol to the exact product configuration

A symbol may be accurate for one model, accessory, package level, or shelf-life configuration and wrong for another. The review file should identify the model, variant, package contents, label level, manual revision, storage statement, and manufacturing responsibility tied to the artwork.

This mapping is especially important in OEM projects that share a housing or dieline across several variants. Reusing artwork without a documented applicability check can carry an unsupported symbol into the wrong configuration.

05

Review legibility, placement, and production output

A technically correct symbol can still fail in production if it is too small, distorted, obscured by a seam, printed with weak contrast, or separated from the information it qualifies. Review the dieline at final size, then inspect a production-representative print or package sample rather than relying only on a zoomed screen view.

Check unit label, carton, manual, pouch, accessory label, and shipping presentation as separate outputs. Define acceptance criteria for placement, contrast, orientation, and reproduction before the supplier releases mass-production files.

06

Control revisions through the artwork handoff

The approved file set should include the symbol inventory, source references, market review, translations where applicable, released dieline, proof, approval record, and production version. File names and informal screenshots are not enough to prove which revision was approved.

If the device, responsible organization, storage conditions, dates, warnings, package contents, standard reference, or market scope changes, trigger a documented labeling impact review. The old artwork should remain archived but blocked from new production use.

07

Reference sources

FDA Use of Symbols in Labeling: https://www.fda.gov/medical-devices/device-labeling/use-symbols-labeling

FDA Use of Symbols in Labeling FAQ: https://www.fda.gov/medical-devices/device-labeling/use-symbols-labeling-frequently-asked-questions

FDA recognized standard record for ISO 15223-1: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/detail.cfm?standard__identification_no=46534

FDA Quality System Regulation Labeling Requirements: https://www.fda.gov/medical-devices/device-labeling/quality-system-regulation-labeling-requirements

Summary

A defensible symbol review connects each icon to a source, meaning, market, product configuration, explanation strategy, print output, and approved revision. That evidence should exist before the carton goes to production.

AXDCARE can coordinate model files, packaging inputs, manual references, artwork proofs, and revision handoff for qualified OEM and distributor projects, while final market compliance remains project-specific.

Related Links

Product and Sourcing Pages

Frequently Asked Questions

Buyer Questions

Can an importer copy label symbols from a competitor package?+

No. Each symbol should be traced to an applicable source and verified against the exact product, market, and released labeling configuration.

Can medical device symbols appear without adjacent text in the United States?+

FDA guidance describes conditions for certain standalone symbols. The project team must verify whether a glossary and glossary-location statement are required for the actual labeling set.

Is ISO 15223-1 a complete artwork approval checklist?+

No. It is one source for symbols. Device-specific labeling, market rules, translations, legibility, product scope, and production controls still require review.

What should trigger a label-symbol review?+

Changes to the device, manufacturer details, storage or date statements, warnings, package contents, market, languages, standard references, or artwork revision should trigger an impact review.

End Article Support

Prepare a controlled artwork review

Share the product, destination market, language plan, current dieline, source documents, and approval timeline for a project-specific discussion.

Contact AXDCARE

Related Reading

More From the News Center

View All Articles